nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ABCB1—kidney cancer	0.176	1	CbGaD
Levothyroxine—SLCO1B3—Paclitaxel—kidney cancer	0.0789	0.143	CbGbCtD
Levothyroxine—SLCO1B1—Pazopanib—kidney cancer	0.0704	0.128	CbGbCtD
Levothyroxine—ABCB1—Temsirolimus—kidney cancer	0.0384	0.0696	CbGbCtD
Levothyroxine—CYP3A4—Everolimus—kidney cancer	0.034	0.0618	CbGbCtD
Levothyroxine—CYP2C8—Pazopanib—kidney cancer	0.0298	0.054	CbGbCtD
Levothyroxine—ALB—Erlotinib—kidney cancer	0.0275	0.0499	CbGbCtD
Levothyroxine—CYP3A4—Temsirolimus—kidney cancer	0.023	0.0417	CbGbCtD
Levothyroxine—CYP2C8—Erlotinib—kidney cancer	0.0213	0.0386	CbGbCtD
Levothyroxine—ABCB1—Pazopanib—kidney cancer	0.0202	0.0366	CbGbCtD
Levothyroxine—CYP2C8—Paclitaxel—kidney cancer	0.0195	0.0353	CbGbCtD
Levothyroxine—ABCB1—Dactinomycin—kidney cancer	0.0184	0.0335	CbGbCtD
Levothyroxine—CYP2C8—Sorafenib—kidney cancer	0.0173	0.0314	CbGbCtD
Levothyroxine—ABCB1—Gemcitabine—kidney cancer	0.0146	0.0264	CbGbCtD
Levothyroxine—ABCB1—Erlotinib—kidney cancer	0.0144	0.0261	CbGbCtD
Levothyroxine—ABCB1—Paclitaxel—kidney cancer	0.0132	0.0239	CbGbCtD
Levothyroxine—CYP3A4—Pazopanib—kidney cancer	0.0121	0.0219	CbGbCtD
Levothyroxine—ABCB1—Sorafenib—kidney cancer	0.0117	0.0212	CbGbCtD
Levothyroxine—ABCB1—Vinblastine—kidney cancer	0.0115	0.021	CbGbCtD
Levothyroxine—ABCB1—Vincristine—kidney cancer	0.0114	0.0206	CbGbCtD
Levothyroxine—ABCB1—Sunitinib—kidney cancer	0.00948	0.0172	CbGbCtD
Levothyroxine—CYP3A4—Erlotinib—kidney cancer	0.00862	0.0156	CbGbCtD
Levothyroxine—CYP3A4—Paclitaxel—kidney cancer	0.00789	0.0143	CbGbCtD
Levothyroxine—TTR—urine—kidney cancer	0.00731	0.105	CbGeAlD
Levothyroxine—ABCB1—Doxorubicin—kidney cancer	0.0071	0.0129	CbGbCtD
Levothyroxine—CYP3A4—Sorafenib—kidney cancer	0.00701	0.0127	CbGbCtD
Levothyroxine—CYP3A4—Vinblastine—kidney cancer	0.00692	0.0126	CbGbCtD
Levothyroxine—CYP3A4—Vincristine—kidney cancer	0.0068	0.0123	CbGbCtD
Levothyroxine—CYP3A4—Sunitinib—kidney cancer	0.00568	0.0103	CbGbCtD
Levothyroxine—CYP3A4—Doxorubicin—kidney cancer	0.00425	0.00772	CbGbCtD
Levothyroxine—SLCO4C1—nephron tubule—kidney cancer	0.00276	0.0398	CbGeAlD
Levothyroxine—SLCO4C1—renal system—kidney cancer	0.00251	0.0362	CbGeAlD
Levothyroxine—SLCO4C1—kidney—kidney cancer	0.00243	0.035	CbGeAlD
Levothyroxine—THRB—renal system—kidney cancer	0.00241	0.0347	CbGeAlD
Levothyroxine—THRA—renal system—kidney cancer	0.00241	0.0347	CbGeAlD
Levothyroxine—SLCO4C1—cortex of kidney—kidney cancer	0.00236	0.0341	CbGeAlD
Levothyroxine—THRA—kidney—kidney cancer	0.00233	0.0336	CbGeAlD
Levothyroxine—THRB—kidney—kidney cancer	0.00233	0.0336	CbGeAlD
Levothyroxine—SLC7A5—Sirolimus—Everolimus—kidney cancer	0.00224	0.5	CbGdCrCtD
Levothyroxine—SLC7A5—Sirolimus—Temsirolimus—kidney cancer	0.00224	0.5	CbGdCrCtD
Levothyroxine—CYP3A4—urine—kidney cancer	0.00222	0.032	CbGeAlD
Levothyroxine—THRA—gonad—kidney cancer	0.00216	0.0311	CbGeAlD
Levothyroxine—THRB—gonad—kidney cancer	0.00216	0.0311	CbGeAlD
Levothyroxine—SLC16A2—cortex of kidney—kidney cancer	0.00205	0.0296	CbGeAlD
Levothyroxine—SLC7A5—nephron tubule—kidney cancer	0.00202	0.0291	CbGeAlD
Levothyroxine—SLCO1C1—renal system—kidney cancer	0.002	0.0289	CbGeAlD
Levothyroxine—SLC16A2—cardiac atrium—kidney cancer	0.00195	0.0282	CbGeAlD
Levothyroxine—SLCO1C1—kidney—kidney cancer	0.00193	0.0279	CbGeAlD
Levothyroxine—TTR—renal system—kidney cancer	0.00179	0.0258	CbGeAlD
Levothyroxine—SLCO4A1—nephron tubule—kidney cancer	0.00176	0.0255	CbGeAlD
Levothyroxine—TTR—kidney—kidney cancer	0.00173	0.025	CbGeAlD
Levothyroxine—SLC7A5—cortex of kidney—kidney cancer	0.00173	0.0249	CbGeAlD
Levothyroxine—SLC7A5—gonad—kidney cancer	0.00165	0.0238	CbGeAlD
Levothyroxine—SLC7A5—cardiac atrium—kidney cancer	0.00164	0.0237	CbGeAlD
Levothyroxine—SLCO4A1—renal system—kidney cancer	0.0016	0.0231	CbGeAlD
Levothyroxine—SLCO4A1—kidney—kidney cancer	0.00155	0.0224	CbGeAlD
Levothyroxine—SLCO4A1—cortex of kidney—kidney cancer	0.00151	0.0218	CbGeAlD
Levothyroxine—SLCO4A1—cardiac atrium—kidney cancer	0.00144	0.0207	CbGeAlD
Levothyroxine—SLCO1B1—renal system—kidney cancer	0.00141	0.0204	CbGeAlD
Levothyroxine—SLCO1B1—kidney—kidney cancer	0.00136	0.0197	CbGeAlD
Levothyroxine—SLCO1A2—renal system—kidney cancer	0.00115	0.0166	CbGeAlD
Levothyroxine—SLCO1A2—kidney—kidney cancer	0.00111	0.016	CbGeAlD
Levothyroxine—CYP2C8—renal system—kidney cancer	0.000802	0.0116	CbGeAlD
Levothyroxine—CYP2C8—kidney—kidney cancer	0.000775	0.0112	CbGeAlD
Levothyroxine—CYP3A4—renal system—kidney cancer	0.000543	0.00784	CbGeAlD
Levothyroxine—CYP3A4—kidney—kidney cancer	0.000525	0.00758	CbGeAlD
Levothyroxine—ABCB1—nephron tubule—kidney cancer	0.000423	0.00611	CbGeAlD
Levothyroxine—ABCB1—renal system—kidney cancer	0.000385	0.00555	CbGeAlD
Levothyroxine—Insomnia—Everolimus—kidney cancer	0.000376	0.00259	CcSEcCtD
Levothyroxine—Pruritus—Pazopanib—kidney cancer	0.000373	0.00256	CcSEcCtD
Levothyroxine—Irritability—Capecitabine—kidney cancer	0.000372	0.00256	CcSEcCtD
Levothyroxine—ABCB1—kidney—kidney cancer	0.000372	0.00537	CbGeAlD
Levothyroxine—Weight decreased—Paclitaxel—kidney cancer	0.000371	0.00256	CcSEcCtD
Levothyroxine—Dyspnoea—Everolimus—kidney cancer	0.000371	0.00255	CcSEcCtD
Levothyroxine—Cardiac arrest—Capecitabine—kidney cancer	0.000371	0.00255	CcSEcCtD
Levothyroxine—Mood swings—Capecitabine—kidney cancer	0.000369	0.00254	CcSEcCtD
Levothyroxine—Convulsion—Sunitinib—kidney cancer	0.000369	0.00254	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000366	0.00252	CcSEcCtD
Levothyroxine—Alopecia—Vincristine—kidney cancer	0.000366	0.00251	CcSEcCtD
Levothyroxine—Insomnia—Erlotinib—kidney cancer	0.000363	0.0025	CcSEcCtD
Levothyroxine—Arthralgia—Sunitinib—kidney cancer	0.000363	0.00249	CcSEcCtD
Levothyroxine—Dehydration—Capecitabine—kidney cancer	0.000363	0.00249	CcSEcCtD
Levothyroxine—ABCB1—cortex of kidney—kidney cancer	0.000362	0.00523	CbGeAlD
Levothyroxine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000361	0.00248	CcSEcCtD
Levothyroxine—Diarrhoea—Pazopanib—kidney cancer	0.000361	0.00248	CcSEcCtD
Levothyroxine—Myocardial infarction—Paclitaxel—kidney cancer	0.000359	0.00247	CcSEcCtD
Levothyroxine—Fatigue—Everolimus—kidney cancer	0.000359	0.00247	CcSEcCtD
Levothyroxine—Dyspnoea—Erlotinib—kidney cancer	0.000358	0.00246	CcSEcCtD
Levothyroxine—Vomiting—Temsirolimus—kidney cancer	0.000356	0.00245	CcSEcCtD
Levothyroxine—Shock—Sorafenib—kidney cancer	0.000355	0.00244	CcSEcCtD
Levothyroxine—Rash—Temsirolimus—kidney cancer	0.000353	0.00243	CcSEcCtD
Levothyroxine—Dermatitis—Temsirolimus—kidney cancer	0.000352	0.00242	CcSEcCtD
Levothyroxine—Arrhythmia—Gemcitabine—kidney cancer	0.000351	0.00241	CcSEcCtD
Levothyroxine—Headache—Temsirolimus—kidney cancer	0.00035	0.00241	CcSEcCtD
Levothyroxine—Alopecia—Gemcitabine—kidney cancer	0.000347	0.00239	CcSEcCtD
Levothyroxine—Fatigue—Erlotinib—kidney cancer	0.000346	0.00238	CcSEcCtD
Levothyroxine—ABCB1—gonad—kidney cancer	0.000345	0.00498	CbGeAlD
Levothyroxine—Feeling abnormal—Vinblastine—kidney cancer	0.000344	0.00237	CcSEcCtD
Levothyroxine—Muscular weakness—Capecitabine—kidney cancer	0.000344	0.00237	CcSEcCtD
Levothyroxine—Feeling abnormal—Everolimus—kidney cancer	0.000343	0.00236	CcSEcCtD
Levothyroxine—Shock—Sunitinib—kidney cancer	0.000342	0.00235	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vinblastine—kidney cancer	0.000342	0.00235	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Everolimus—kidney cancer	0.00034	0.00234	CcSEcCtD
Levothyroxine—Dysphagia—Capecitabine—kidney cancer	0.000337	0.00232	CcSEcCtD
Levothyroxine—Vomiting—Pazopanib—kidney cancer	0.000335	0.0023	CcSEcCtD
Levothyroxine—Rash—Pazopanib—kidney cancer	0.000332	0.00229	CcSEcCtD
Levothyroxine—Nausea—Temsirolimus—kidney cancer	0.000332	0.00229	CcSEcCtD
Levothyroxine—Dermatitis—Pazopanib—kidney cancer	0.000332	0.00228	CcSEcCtD
Levothyroxine—Agitation—Vincristine—kidney cancer	0.000331	0.00228	CcSEcCtD
Levothyroxine—Abdominal pain—Vinblastine—kidney cancer	0.00033	0.00227	CcSEcCtD
Levothyroxine—Headache—Pazopanib—kidney cancer	0.00033	0.00227	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000329	0.00226	CcSEcCtD
Levothyroxine—Abdominal pain—Everolimus—kidney cancer	0.000329	0.00226	CcSEcCtD
Levothyroxine—Body temperature increased—Everolimus—kidney cancer	0.000329	0.00226	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000328	0.00226	CcSEcCtD
Levothyroxine—Angina pectoris—Capecitabine—kidney cancer	0.000328	0.00226	CcSEcCtD
Levothyroxine—Sweating increased—Capecitabine—kidney cancer	0.000328	0.00226	CcSEcCtD
Levothyroxine—Dyspnoea—Sorafenib—kidney cancer	0.000322	0.00221	CcSEcCtD
Levothyroxine—Abdominal pain—Erlotinib—kidney cancer	0.000317	0.00218	CcSEcCtD
Levothyroxine—Body temperature increased—Erlotinib—kidney cancer	0.000317	0.00218	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000317	0.00218	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—kidney cancer	0.000316	0.00218	CcSEcCtD
Levothyroxine—Insomnia—Sunitinib—kidney cancer	0.000314	0.00216	CcSEcCtD
Levothyroxine—Nausea—Pazopanib—kidney cancer	0.000313	0.00215	CcSEcCtD
Levothyroxine—Convulsion—Vincristine—kidney cancer	0.000312	0.00215	CcSEcCtD
Levothyroxine—Fatigue—Sorafenib—kidney cancer	0.000311	0.00214	CcSEcCtD
Levothyroxine—Dyspnoea—Sunitinib—kidney cancer	0.00031	0.00213	CcSEcCtD
Levothyroxine—Flushing—Paclitaxel—kidney cancer	0.000305	0.0021	CcSEcCtD
Levothyroxine—Weight decreased—Capecitabine—kidney cancer	0.000305	0.0021	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.0003	0.00206	CcSEcCtD
Levothyroxine—Asthenia—Vinblastine—kidney cancer	0.0003	0.00206	CcSEcCtD
Levothyroxine—Fatigue—Sunitinib—kidney cancer	0.0003	0.00206	CcSEcCtD
Levothyroxine—Asthenia—Everolimus—kidney cancer	0.000299	0.00205	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Capecitabine—kidney cancer	0.000296	0.00204	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000295	0.00203	CcSEcCtD
Levothyroxine—Myocardial infarction—Capecitabine—kidney cancer	0.000295	0.00203	CcSEcCtD
Levothyroxine—Pruritus—Everolimus—kidney cancer	0.000294	0.00202	CcSEcCtD
Levothyroxine—Arrhythmia—Paclitaxel—kidney cancer	0.000294	0.00202	CcSEcCtD
Levothyroxine—Arthralgia—Gemcitabine—kidney cancer	0.000291	0.002	CcSEcCtD
Levothyroxine—Alopecia—Paclitaxel—kidney cancer	0.00029	0.002	CcSEcCtD
Levothyroxine—Asthenia—Erlotinib—kidney cancer	0.000288	0.00198	CcSEcCtD
Levothyroxine—Urticaria—Sorafenib—kidney cancer	0.000287	0.00197	CcSEcCtD
Levothyroxine—Diarrhoea—Vinblastine—kidney cancer	0.000286	0.00197	CcSEcCtD
Levothyroxine—Body temperature increased—Sorafenib—kidney cancer	0.000286	0.00196	CcSEcCtD
Levothyroxine—Abdominal pain—Sorafenib—kidney cancer	0.000286	0.00196	CcSEcCtD
Levothyroxine—Diarrhoea—Everolimus—kidney cancer	0.000285	0.00196	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000284	0.00195	CcSEcCtD
Levothyroxine—Hyperhidrosis—Vincristine—kidney cancer	0.000284	0.00195	CcSEcCtD
Levothyroxine—Pruritus—Erlotinib—kidney cancer	0.000284	0.00195	CcSEcCtD
Levothyroxine—Fatigue—Dactinomycin—kidney cancer	0.000284	0.00195	CcSEcCtD
Levothyroxine—Tension—Paclitaxel—kidney cancer	0.000281	0.00193	CcSEcCtD
Levothyroxine—Nervousness—Paclitaxel—kidney cancer	0.000278	0.00191	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000277	0.00191	CcSEcCtD
Levothyroxine—Body temperature increased—Sunitinib—kidney cancer	0.000275	0.00189	CcSEcCtD
Levothyroxine—Abdominal pain—Sunitinib—kidney cancer	0.000275	0.00189	CcSEcCtD
Levothyroxine—Diarrhoea—Erlotinib—kidney cancer	0.000275	0.00189	CcSEcCtD
Levothyroxine—Feeling abnormal—Dactinomycin—kidney cancer	0.000271	0.00186	CcSEcCtD
Levothyroxine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00027	0.00185	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000269	0.00185	CcSEcCtD
Levothyroxine—Tremor—Paclitaxel—kidney cancer	0.000268	0.00184	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000268	0.00184	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—kidney cancer	0.000267	0.00184	CcSEcCtD
Levothyroxine—Insomnia—Vincristine—kidney cancer	0.000266	0.00183	CcSEcCtD
Levothyroxine—Vomiting—Vinblastine—kidney cancer	0.000266	0.00183	CcSEcCtD
Levothyroxine—Vomiting—Everolimus—kidney cancer	0.000265	0.00182	CcSEcCtD
Levothyroxine—Agitation—Paclitaxel—kidney cancer	0.000263	0.00181	CcSEcCtD
Levothyroxine—Rash—Everolimus—kidney cancer	0.000262	0.0018	CcSEcCtD
Levothyroxine—Dermatitis—Everolimus—kidney cancer	0.000262	0.0018	CcSEcCtD
Levothyroxine—Headache—Vinblastine—kidney cancer	0.000262	0.0018	CcSEcCtD
Levothyroxine—Angioedema—Paclitaxel—kidney cancer	0.000261	0.0018	CcSEcCtD
Levothyroxine—Headache—Everolimus—kidney cancer	0.000261	0.00179	CcSEcCtD
Levothyroxine—Body temperature increased—Dactinomycin—kidney cancer	0.00026	0.00179	CcSEcCtD
Levothyroxine—Abdominal pain—Dactinomycin—kidney cancer	0.00026	0.00179	CcSEcCtD
Levothyroxine—Asthenia—Sorafenib—kidney cancer	0.000259	0.00178	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—kidney cancer	0.000258	0.00177	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000258	0.00177	CcSEcCtD
Levothyroxine—Pruritus—Sorafenib—kidney cancer	0.000256	0.00176	CcSEcCtD
Levothyroxine—Vomiting—Erlotinib—kidney cancer	0.000255	0.00176	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000254	0.00175	CcSEcCtD
Levothyroxine—Fatigue—Vincristine—kidney cancer	0.000253	0.00174	CcSEcCtD
Levothyroxine—Rash—Erlotinib—kidney cancer	0.000253	0.00174	CcSEcCtD
Levothyroxine—Dermatitis—Erlotinib—kidney cancer	0.000253	0.00174	CcSEcCtD
Levothyroxine—Palpitations—Paclitaxel—kidney cancer	0.000253	0.00174	CcSEcCtD
Levothyroxine—Insomnia—Gemcitabine—kidney cancer	0.000252	0.00173	CcSEcCtD
Levothyroxine—Headache—Erlotinib—kidney cancer	0.000252	0.00173	CcSEcCtD
Levothyroxine—Flushing—Capecitabine—kidney cancer	0.00025	0.00172	CcSEcCtD
Levothyroxine—Asthenia—Sunitinib—kidney cancer	0.000249	0.00172	CcSEcCtD
Levothyroxine—Dyspnoea—Gemcitabine—kidney cancer	0.000249	0.00171	CcSEcCtD
Levothyroxine—Nausea—Vinblastine—kidney cancer	0.000248	0.00171	CcSEcCtD
Levothyroxine—Convulsion—Paclitaxel—kidney cancer	0.000248	0.0017	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—kidney cancer	0.000247	0.0017	CcSEcCtD
Levothyroxine—Nausea—Everolimus—kidney cancer	0.000247	0.0017	CcSEcCtD
Levothyroxine—Diarrhoea—Sorafenib—kidney cancer	0.000247	0.0017	CcSEcCtD
Levothyroxine—Pruritus—Sunitinib—kidney cancer	0.000246	0.00169	CcSEcCtD
Levothyroxine—Arthralgia—Paclitaxel—kidney cancer	0.000244	0.00168	CcSEcCtD
Levothyroxine—Anxiety—Paclitaxel—kidney cancer	0.000243	0.00167	CcSEcCtD
Levothyroxine—Arrhythmia—Capecitabine—kidney cancer	0.000241	0.00166	CcSEcCtD
Levothyroxine—Fatigue—Gemcitabine—kidney cancer	0.00024	0.00165	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vincristine—kidney cancer	0.00024	0.00165	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—kidney cancer	0.000239	0.00164	CcSEcCtD
Levothyroxine—Nausea—Erlotinib—kidney cancer	0.000238	0.00164	CcSEcCtD
Levothyroxine—Alopecia—Capecitabine—kidney cancer	0.000238	0.00164	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—kidney cancer	0.000238	0.00164	CcSEcCtD
Levothyroxine—Diarrhoea—Sunitinib—kidney cancer	0.000238	0.00164	CcSEcCtD
Levothyroxine—Asthenia—Dactinomycin—kidney cancer	0.000236	0.00162	CcSEcCtD
Levothyroxine—Confusional state—Paclitaxel—kidney cancer	0.000235	0.00162	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—kidney cancer	0.000234	0.00161	CcSEcCtD
Levothyroxine—Abdominal pain—Vincristine—kidney cancer	0.000232	0.0016	CcSEcCtD
Levothyroxine—Body temperature increased—Vincristine—kidney cancer	0.000232	0.0016	CcSEcCtD
Levothyroxine—Feeling abnormal—Gemcitabine—kidney cancer	0.00023	0.00158	CcSEcCtD
Levothyroxine—Shock—Paclitaxel—kidney cancer	0.00023	0.00158	CcSEcCtD
Levothyroxine—Vomiting—Sorafenib—kidney cancer	0.00023	0.00158	CcSEcCtD
Levothyroxine—Tachycardia—Paclitaxel—kidney cancer	0.000228	0.00157	CcSEcCtD
Levothyroxine—Rash—Sorafenib—kidney cancer	0.000228	0.00157	CcSEcCtD
Levothyroxine—Dermatitis—Sorafenib—kidney cancer	0.000228	0.00157	CcSEcCtD
Levothyroxine—Headache—Sorafenib—kidney cancer	0.000226	0.00156	CcSEcCtD
Levothyroxine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000226	0.00155	CcSEcCtD
Levothyroxine—Diarrhoea—Dactinomycin—kidney cancer	0.000225	0.00155	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—kidney cancer	0.000222	0.00152	CcSEcCtD
Levothyroxine—Vomiting—Sunitinib—kidney cancer	0.000221	0.00152	CcSEcCtD
Levothyroxine—Body temperature increased—Gemcitabine—kidney cancer	0.00022	0.00152	CcSEcCtD
Levothyroxine—Tremor—Capecitabine—kidney cancer	0.00022	0.00151	CcSEcCtD
Levothyroxine—Rash—Sunitinib—kidney cancer	0.000219	0.00151	CcSEcCtD
Levothyroxine—Dermatitis—Sunitinib—kidney cancer	0.000219	0.00151	CcSEcCtD
Levothyroxine—Headache—Sunitinib—kidney cancer	0.000218	0.0015	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—kidney cancer	0.000217	0.00149	CcSEcCtD
Levothyroxine—Nausea—Sorafenib—kidney cancer	0.000215	0.00148	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000213	0.00146	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—kidney cancer	0.000212	0.00146	CcSEcCtD
Levothyroxine—Insomnia—Paclitaxel—kidney cancer	0.000211	0.00145	CcSEcCtD
Levothyroxine—Asthenia—Vincristine—kidney cancer	0.000211	0.00145	CcSEcCtD
Levothyroxine—Vomiting—Dactinomycin—kidney cancer	0.000209	0.00144	CcSEcCtD
Levothyroxine—Dyspnoea—Paclitaxel—kidney cancer	0.000208	0.00143	CcSEcCtD
Levothyroxine—Palpitations—Capecitabine—kidney cancer	0.000207	0.00143	CcSEcCtD
Levothyroxine—Rash—Dactinomycin—kidney cancer	0.000207	0.00143	CcSEcCtD
Levothyroxine—Nausea—Sunitinib—kidney cancer	0.000206	0.00142	CcSEcCtD
Levothyroxine—Fatigue—Paclitaxel—kidney cancer	0.000201	0.00138	CcSEcCtD
Levothyroxine—Diarrhoea—Vincristine—kidney cancer	0.000201	0.00138	CcSEcCtD
Levothyroxine—Asthenia—Gemcitabine—kidney cancer	0.0002	0.00138	CcSEcCtD
Levothyroxine—Arthralgia—Capecitabine—kidney cancer	0.0002	0.00137	CcSEcCtD
Levothyroxine—Anxiety—Capecitabine—kidney cancer	0.000199	0.00137	CcSEcCtD
Levothyroxine—Pruritus—Gemcitabine—kidney cancer	0.000197	0.00136	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—kidney cancer	0.000197	0.00135	CcSEcCtD
Levothyroxine—Nausea—Dactinomycin—kidney cancer	0.000195	0.00134	CcSEcCtD
Levothyroxine—Confusional state—Capecitabine—kidney cancer	0.000193	0.00133	CcSEcCtD
Levothyroxine—Feeling abnormal—Paclitaxel—kidney cancer	0.000192	0.00132	CcSEcCtD
Levothyroxine—Liotrix—ABCB1—kidney cancer	0.000192	0.578	CrCbGaD
Levothyroxine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000191	0.00131	CcSEcCtD
Levothyroxine—Diarrhoea—Gemcitabine—kidney cancer	0.000191	0.00131	CcSEcCtD
Levothyroxine—Shock—Capecitabine—kidney cancer	0.000189	0.0013	CcSEcCtD
Levothyroxine—Tachycardia—Capecitabine—kidney cancer	0.000187	0.00129	CcSEcCtD
Levothyroxine—Vomiting—Vincristine—kidney cancer	0.000187	0.00129	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—kidney cancer	0.000186	0.00128	CcSEcCtD
Levothyroxine—Urticaria—Paclitaxel—kidney cancer	0.000186	0.00128	CcSEcCtD
Levothyroxine—Rash—Vincristine—kidney cancer	0.000185	0.00127	CcSEcCtD
Levothyroxine—Hyperhidrosis—Capecitabine—kidney cancer	0.000185	0.00127	CcSEcCtD
Levothyroxine—Dermatitis—Vincristine—kidney cancer	0.000185	0.00127	CcSEcCtD
Levothyroxine—Abdominal pain—Paclitaxel—kidney cancer	0.000185	0.00127	CcSEcCtD
Levothyroxine—Body temperature increased—Paclitaxel—kidney cancer	0.000185	0.00127	CcSEcCtD
Levothyroxine—Headache—Vincristine—kidney cancer	0.000184	0.00127	CcSEcCtD
Levothyroxine—Vomiting—Gemcitabine—kidney cancer	0.000177	0.00122	CcSEcCtD
Levothyroxine—Rash—Gemcitabine—kidney cancer	0.000176	0.00121	CcSEcCtD
Levothyroxine—Dermatitis—Gemcitabine—kidney cancer	0.000176	0.00121	CcSEcCtD
Levothyroxine—Headache—Gemcitabine—kidney cancer	0.000175	0.0012	CcSEcCtD
Levothyroxine—Nausea—Vincristine—kidney cancer	0.000175	0.0012	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000175	0.0012	CcSEcCtD
Levothyroxine—Insomnia—Capecitabine—kidney cancer	0.000173	0.00119	CcSEcCtD
Levothyroxine—Dyspnoea—Capecitabine—kidney cancer	0.000171	0.00118	CcSEcCtD
Levothyroxine—Asthenia—Paclitaxel—kidney cancer	0.000168	0.00115	CcSEcCtD
Levothyroxine—Nausea—Gemcitabine—kidney cancer	0.000166	0.00114	CcSEcCtD
Levothyroxine—Fatigue—Capecitabine—kidney cancer	0.000165	0.00114	CcSEcCtD
Levothyroxine—Pruritus—Paclitaxel—kidney cancer	0.000165	0.00114	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—kidney cancer	0.000161	0.00111	CcSEcCtD
Levothyroxine—Diarrhoea—Paclitaxel—kidney cancer	0.00016	0.0011	CcSEcCtD
Levothyroxine—Feeling abnormal—Capecitabine—kidney cancer	0.000158	0.00109	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000157	0.00108	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—kidney cancer	0.000155	0.00107	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—kidney cancer	0.000154	0.00106	CcSEcCtD
Levothyroxine—Urticaria—Capecitabine—kidney cancer	0.000152	0.00105	CcSEcCtD
Levothyroxine—Abdominal pain—Capecitabine—kidney cancer	0.000151	0.00104	CcSEcCtD
Levothyroxine—Body temperature increased—Capecitabine—kidney cancer	0.000151	0.00104	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—kidney cancer	0.000149	0.00102	CcSEcCtD
Levothyroxine—Vomiting—Paclitaxel—kidney cancer	0.000148	0.00102	CcSEcCtD
Levothyroxine—Rash—Paclitaxel—kidney cancer	0.000147	0.00101	CcSEcCtD
Levothyroxine—Dermatitis—Paclitaxel—kidney cancer	0.000147	0.00101	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—kidney cancer	0.000147	0.00101	CcSEcCtD
Levothyroxine—Headache—Paclitaxel—kidney cancer	0.000146	0.00101	CcSEcCtD
Levothyroxine—Liothyronine—ABCB1—kidney cancer	0.00014	0.422	CrCbGaD
Levothyroxine—Agitation—Doxorubicin—kidney cancer	0.000139	0.000957	CcSEcCtD
Levothyroxine—Nausea—Paclitaxel—kidney cancer	0.000139	0.000954	CcSEcCtD
Levothyroxine—Asthenia—Capecitabine—kidney cancer	0.000137	0.000946	CcSEcCtD
Levothyroxine—Pruritus—Capecitabine—kidney cancer	0.000136	0.000932	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—kidney cancer	0.000134	0.00092	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—kidney cancer	0.000131	0.000902	CcSEcCtD
Levothyroxine—Diarrhoea—Capecitabine—kidney cancer	0.000131	0.000902	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—kidney cancer	0.000129	0.000886	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—kidney cancer	0.000128	0.000883	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—kidney cancer	0.000125	0.000857	CcSEcCtD
Levothyroxine—Vomiting—Capecitabine—kidney cancer	0.000122	0.000838	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—kidney cancer	0.000122	0.000836	CcSEcCtD
Levothyroxine—Rash—Capecitabine—kidney cancer	0.000121	0.000831	CcSEcCtD
Levothyroxine—Dermatitis—Capecitabine—kidney cancer	0.000121	0.00083	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—kidney cancer	0.000121	0.000829	CcSEcCtD
Levothyroxine—Headache—Capecitabine—kidney cancer	0.00012	0.000826	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000119	0.000821	CcSEcCtD
Levothyroxine—Nausea—Capecitabine—kidney cancer	0.000114	0.000783	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000113	0.000774	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—kidney cancer	0.000112	0.000768	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—kidney cancer	0.00011	0.000757	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—kidney cancer	0.000106	0.000732	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—kidney cancer	0.000102	0.0007	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000101	0.000695	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—kidney cancer	9.81e-05	0.000675	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—kidney cancer	9.76e-05	0.000672	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—kidney cancer	9.76e-05	0.000672	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—kidney cancer	8.86e-05	0.00061	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—kidney cancer	8.74e-05	0.000601	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—kidney cancer	8.45e-05	0.000581	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—kidney cancer	7.85e-05	0.00054	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—kidney cancer	7.79e-05	0.000536	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—kidney cancer	7.78e-05	0.000535	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—kidney cancer	7.74e-05	0.000532	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—kidney cancer	7.34e-05	0.000505	CcSEcCtD
Levothyroxine—ABCB1—Metabolism—GLIPR1—kidney cancer	1.83e-05	0.00034	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPAT—kidney cancer	1.83e-05	0.00034	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TSC2—kidney cancer	1.83e-05	0.00034	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPC3—kidney cancer	1.83e-05	0.00034	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PSMD7—kidney cancer	1.83e-05	0.000339	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.82e-05	0.000339	CbGpPWpGaD
Levothyroxine—TTR—Disease—RAF1—kidney cancer	1.81e-05	0.000336	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNA2—kidney cancer	1.79e-05	0.000333	CbGpPWpGaD
Levothyroxine—TTR—Disease—ERBB2—kidney cancer	1.79e-05	0.000333	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CA2—kidney cancer	1.79e-05	0.000332	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.78e-05	0.000332	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.78e-05	0.000331	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CA2—kidney cancer	1.78e-05	0.00033	CbGpPWpGaD
Levothyroxine—TTR—Disease—MTOR—kidney cancer	1.77e-05	0.000329	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD4—kidney cancer	1.76e-05	0.000328	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KDR—kidney cancer	1.75e-05	0.000326	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTP1—kidney cancer	1.75e-05	0.000326	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTGS2—kidney cancer	1.75e-05	0.000326	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALAD—kidney cancer	1.74e-05	0.000324	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALAD—kidney cancer	1.73e-05	0.000322	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—BCHE—kidney cancer	1.73e-05	0.000322	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.72e-05	0.000321	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.72e-05	0.00032	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.72e-05	0.000319	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SLC5A5—kidney cancer	1.71e-05	0.000318	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—FH—kidney cancer	1.7e-05	0.000316	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APRT—kidney cancer	1.7e-05	0.000316	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.7e-05	0.000316	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ACHE—kidney cancer	1.7e-05	0.000316	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.7e-05	0.000316	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.7e-05	0.000316	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ST3GAL2—kidney cancer	1.69e-05	0.000314	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.68e-05	0.000312	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.66e-05	0.000309	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ABCB1—kidney cancer	1.66e-05	0.000308	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDKN1B—kidney cancer	1.66e-05	0.000308	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALDH1A1—kidney cancer	1.65e-05	0.000307	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SLC2A1—kidney cancer	1.65e-05	0.000307	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.64e-05	0.000305	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ACY1—kidney cancer	1.63e-05	0.000303	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APC—kidney cancer	1.61e-05	0.0003	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KIT—kidney cancer	1.61e-05	0.0003	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IGF2—kidney cancer	1.61e-05	0.0003	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTM1—kidney cancer	1.61e-05	0.000299	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.61e-05	0.000299	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.6e-05	0.000298	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPC3—kidney cancer	1.6e-05	0.000298	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.59e-05	0.000296	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PGK1—kidney cancer	1.59e-05	0.000296	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.59e-05	0.000296	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PGK1—kidney cancer	1.58e-05	0.000294	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A3—kidney cancer	1.58e-05	0.000294	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.57e-05	0.000293	CbGpPWpGaD
Levothyroxine—TTR—Disease—CTNNB1—kidney cancer	1.57e-05	0.000291	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.56e-05	0.00029	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—LDHB—kidney cancer	1.56e-05	0.00029	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.56e-05	0.00029	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CA2—kidney cancer	1.56e-05	0.000289	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.56e-05	0.000289	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—LDHB—kidney cancer	1.55e-05	0.000289	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.55e-05	0.000287	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—POMC—kidney cancer	1.54e-05	0.000286	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTEN—kidney cancer	1.53e-05	0.000284	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP1A1—kidney cancer	1.53e-05	0.000284	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—BRAF—kidney cancer	1.52e-05	0.000282	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALAD—kidney cancer	1.52e-05	0.000282	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.51e-05	0.000281	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.48e-05	0.000276	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.48e-05	0.000275	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.48e-05	0.000275	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—BCHE—kidney cancer	1.48e-05	0.000275	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.47e-05	0.000273	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.46e-05	0.000272	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.45e-05	0.000269	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.43e-05	0.000266	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.41e-05	0.000262	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.4e-05	0.00026	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PGK1—kidney cancer	1.39e-05	0.000258	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A3—kidney cancer	1.39e-05	0.000258	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PDHB—kidney cancer	1.38e-05	0.000257	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.38e-05	0.000256	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTP1—kidney cancer	1.38e-05	0.000256	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.37e-05	0.000255	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LDHB—kidney cancer	1.36e-05	0.000253	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.36e-05	0.000253	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CA9—kidney cancer	1.35e-05	0.000252	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CA9—kidney cancer	1.35e-05	0.00025	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.35e-05	0.00025	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.32e-05	0.000246	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.32e-05	0.000245	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.31e-05	0.000244	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK3—kidney cancer	1.3e-05	0.000243	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.3e-05	0.000242	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.3e-05	0.000242	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.29e-05	0.00024	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—kidney cancer	1.27e-05	0.000236	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RAF1—kidney cancer	1.27e-05	0.000236	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.27e-05	0.000235	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RELA—kidney cancer	1.26e-05	0.000235	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.25e-05	0.000233	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—kidney cancer	1.25e-05	0.000233	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.24e-05	0.000231	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK1—kidney cancer	1.24e-05	0.000231	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MTOR—kidney cancer	1.24e-05	0.00023	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.22e-05	0.000227	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.2e-05	0.000223	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.19e-05	0.000222	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.19e-05	0.000221	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.18e-05	0.00022	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CA9—kidney cancer	1.18e-05	0.000219	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.18e-05	0.000219	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—kidney cancer	1.17e-05	0.000218	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.16e-05	0.000216	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1B—kidney cancer	1.16e-05	0.000216	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CRABP1—kidney cancer	1.15e-05	0.000214	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000213	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—POMC—kidney cancer	1.14e-05	0.000212	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—kidney cancer	1.14e-05	0.000211	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPAT—kidney cancer	1.13e-05	0.00021	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.13e-05	0.00021	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.11e-05	0.000207	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—kidney cancer	1.11e-05	0.000206	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—JUN—kidney cancer	1.11e-05	0.000206	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.1e-05	0.000204	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—kidney cancer	1.1e-05	0.000204	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.08e-05	0.000201	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—kidney cancer	1.08e-05	0.0002	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ITPR2—kidney cancer	1.07e-05	0.000199	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—kidney cancer	1.07e-05	0.000199	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000198	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FH—kidney cancer	1.05e-05	0.000195	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APRT—kidney cancer	1.05e-05	0.000195	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.03e-05	0.000191	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.03e-05	0.000191	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.01e-05	0.000188	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CRABP1—kidney cancer	1e-05	0.000186	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.87e-06	0.000183	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPC3—kidney cancer	9.86e-06	0.000183	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.85e-06	0.000183	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.81e-06	0.000182	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.77e-06	0.000182	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTT1—kidney cancer	9.76e-06	0.000181	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ACHE—kidney cancer	9.76e-06	0.000181	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ACHE—kidney cancer	9.7e-06	0.00018	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTT1—kidney cancer	9.7e-06	0.00018	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—kidney cancer	9.66e-06	0.00018	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA2—kidney cancer	9.59e-06	0.000178	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALAD—kidney cancer	9.35e-06	0.000174	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ITPR2—kidney cancer	9.32e-06	0.000173	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SCARB1—kidney cancer	9.24e-06	0.000172	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SCARB1—kidney cancer	9.19e-06	0.000171	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS1—kidney cancer	9.15e-06	0.00017	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—kidney cancer	9.13e-06	0.00017	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.12e-06	0.00017	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS1—kidney cancer	9.09e-06	0.000169	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—kidney cancer	9.08e-06	0.000169	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PSMD7—kidney cancer	8.97e-06	0.000167	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—POMC—kidney cancer	8.94e-06	0.000166	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PSMD7—kidney cancer	8.92e-06	0.000166	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.92e-06	0.000166	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAF1—kidney cancer	8.89e-06	0.000165	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—kidney cancer	8.88e-06	0.000165	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK1—kidney cancer	8.69e-06	0.000162	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PGK1—kidney cancer	8.55e-06	0.000159	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.55e-06	0.000159	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—kidney cancer	8.5e-06	0.000158	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ACHE—kidney cancer	8.5e-06	0.000158	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—BCHE—kidney cancer	8.5e-06	0.000158	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—BCHE—kidney cancer	8.45e-06	0.000157	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.43e-06	0.000157	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.4e-06	0.000156	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LDHB—kidney cancer	8.38e-06	0.000156	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A5—kidney cancer	8.35e-06	0.000155	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—kidney cancer	8.21e-06	0.000153	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.11e-06	0.000151	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC2A1—kidney cancer	8.07e-06	0.00015	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SCARB1—kidney cancer	8.05e-06	0.00015	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS1—kidney cancer	7.97e-06	0.000148	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—kidney cancer	7.97e-06	0.000148	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—kidney cancer	7.92e-06	0.000147	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.87e-06	0.000146	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.83e-06	0.000146	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PSMD7—kidney cancer	7.81e-06	0.000145	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.69e-06	0.000143	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—POMC—kidney cancer	7.65e-06	0.000142	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—kidney cancer	7.54e-06	0.00014	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BCHE—kidney cancer	7.41e-06	0.000138	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A5—kidney cancer	7.32e-06	0.000136	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—kidney cancer	7.3e-06	0.000136	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA9—kidney cancer	7.27e-06	0.000135	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—kidney cancer	7.13e-06	0.000133	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC2A1—kidney cancer	7.07e-06	0.000131	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.86e-06	0.000128	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.82e-06	0.000127	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—kidney cancer	6.77e-06	0.000126	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—kidney cancer	6.77e-06	0.000126	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.74e-06	0.000125	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—kidney cancer	6.73e-06	0.000125	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—kidney cancer	6.4e-06	0.000119	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—kidney cancer	6.4e-06	0.000119	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—kidney cancer	6.37e-06	0.000118	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—kidney cancer	6.22e-06	0.000116	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—kidney cancer	6.22e-06	0.000116	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—kidney cancer	6.18e-06	0.000115	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CRABP1—kidney cancer	6.18e-06	0.000115	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—kidney cancer	6.1e-06	0.000113	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK1—kidney cancer	6.09e-06	0.000113	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—kidney cancer	5.89e-06	0.00011	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.89e-06	0.00011	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1A1—kidney cancer	5.86e-06	0.000109	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—kidney cancer	5.76e-06	0.000107	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ITPR2—kidney cancer	5.74e-06	0.000107	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—kidney cancer	5.59e-06	0.000104	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—kidney cancer	5.42e-06	0.000101	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—kidney cancer	5.32e-06	9.89e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—kidney cancer	5.29e-06	9.83e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—kidney cancer	5.24e-06	9.74e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ACHE—kidney cancer	5.24e-06	9.74e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1A1—kidney cancer	5.13e-06	9.55e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—kidney cancer	5.12e-06	9.51e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SCARB1—kidney cancer	4.96e-06	9.22e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS1—kidney cancer	4.91e-06	9.13e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.84e-06	9e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.81e-06	8.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.81e-06	8.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BCHE—kidney cancer	4.56e-06	8.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.51e-06	8.38e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—POMC—kidney cancer	4.39e-06	8.17e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—kidney cancer	4.39e-06	8.16e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—POMC—kidney cancer	4.37e-06	8.12e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.35e-06	8.1e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—POMC—kidney cancer	3.83e-06	7.12e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.75e-06	6.98e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.63e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—kidney cancer	3.5e-06	6.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—kidney cancer	3.48e-06	6.48e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.44e-06	6.39e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.34e-06	6.2e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.16e-06	5.88e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—kidney cancer	3.06e-06	5.68e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—kidney cancer	3.05e-06	5.68e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—kidney cancer	3.04e-06	5.65e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—kidney cancer	2.66e-06	4.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—POMC—kidney cancer	2.36e-06	4.39e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.16e-06	4.01e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—kidney cancer	2.14e-06	3.99e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.88e-06	3.5e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.88e-06	3.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—kidney cancer	1.64e-06	3.05e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.16e-06	2.15e-05	CbGpPWpGaD
